HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single blind study to evaluate the efficacy and safety of naproxen gel compared with diclophenac emulgel in the treatment of soft tissue injuries.

Abstract
Sixty four adult patients of both genders with injuries such as contusions and sprains were studied. Of these, 34 were treated with 10% naproxen gel and 30 with 1% dichlophenaco gel topically given for 4 days. Various pain modalities, edema and functional alterations of areas involved were studied. Naproxen reduced spontaneous pain slightly better than dichlophenaco. Both drugs resulted in significant reduction of other pain modalities, edema and functional alterations (p < 0.001). A lower percentage (29%) of naproxen patients used paracetamol as additional pain reliever compared to dichlophenaco patients (36%). Local adverse events were minimum for both groups.
AuthorsF Butrón, A Galicia, G Zamora, F Martinez-Zurita
JournalProceedings of the Western Pharmacology Society (Proc West Pharmacol Soc) Vol. 37 Pg. 153-6 ( 1994) ISSN: 0083-8969 [Print] United States
PMID7984652 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Gels
  • Diclofenac
  • Naproxen
Topics
  • Adult
  • Contusions (drug therapy)
  • Diclofenac (administration & dosage, therapeutic use)
  • Edema (drug therapy)
  • Female
  • Gels
  • Humans
  • Male
  • Middle Aged
  • Naproxen (administration & dosage, therapeutic use)
  • Pain Measurement
  • Single-Blind Method
  • Soft Tissue Injuries (drug therapy)
  • Sprains and Strains (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: